Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT

Cell

Volumn 174, Issue 6, 2018, Pages 1406-1423.e16

  Suez, Jotham ^a   Zmora, Niv ^a,b   Zilberman Schapira, Gili ^a   Mor, Uria ^a   Dori Bachash, Mally ^a   Bashiardes, Stavros ^a   Zur, Maya ^a   Regev Lehavi, Dana ^a   Ben Zeev Brik, Rotem ^a   Federici, Sara ^a   Horn, Max ^a   Cohen, Yotam ^a   Moor, Andreas E ^a   Zeevi, David ^a   Korem, Tal ^a   Kotler, Eran ^a   Harmelin, Alon ^a   Itzkovitz, Shalev ^a   Maharshak, Nitsan ^b,c   Shibolet, Oren ^b,c   Pevsner Fischer, Meirav ^a   Shapiro, Hagit ^a   Sharon, Itai ^d,e   Halpern, Zamir ^b,c   Segal, Eran ^a   Elinav, Eran ^a   more..

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^e TEL HAI COLLEGE   (Israel)

Author keywords

antibiotics; microbiome; Probiotics

Indexed keywords

CIPROFLOXACIN; CIPROFLOXACIN PLUS DEXAMETHASONE; METRONIDAZOLE; PROBIOTIC AGENT; SUPHERB BIO 25; TRANSCRIPTOME; ANTIINFECTIVE AGENT; RNA 16S;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; AUTOLOGOUS FECAL MICROBIOTA TRANSPLANTATION; BACTERIAL COLONIZATION; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; CONTROLLED STUDY; DRUG EFFECT; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTERVENTION STUDY; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LACTOCOCCUS LACTIS; LONGITUDINAL STUDY; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; STREPTOCOCCUS THERMOPHILUS; WATCHFUL WAITING; ADOLESCENT; ANIMAL; C57BL MOUSE; CLINICAL TRIAL; FECES; GENETICS; ISOLATION AND PURIFICATION; LACTOBACILLUS; LACTOCOCCUS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTI-BACTERIAL AGENTS; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; LACTOBACILLUS; LACTOCOCCUS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PROBIOTICS; RNA, RIBOSOMAL, 16S; YOUNG ADULT;

EID: 85052739697     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2018.08.047     Document Type: Article

References (61)

1. Adiconis, X., Borges-Rivera, D., Satija, R., DeLuca, D.S., Busby, M.A., Berlin, A.M., Sivachenko, A., Thompson, D.A., Wysoker, A., Fennell, T., et al. Comparative analysis of RNA sequencing methods for degraded or low-input samples. Nat. Methods 10 (2013), 623–629.
2. Allen, S.J., Wareham, K., Wang, D., Bradley, C., Hutchings, H., Harris, W., Dhar, A., Brown, H., Foden, A., Gravenor, M.B., Mack, D., Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 382 (2013), 1249–1257.
3. Arvonen, M., Virta, L.J., Pokka, T., Kröger, L., Vähäsalo, P., Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections?. J. Rheumatol. 42 (2015), 521–526.
4. Bafeta, A., Koh, M., Riveros, C., Ravaud, P., Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota: A Systematic Review. Ann. Intern. Med., 2018, 10.7326/M18-0343 Published online July 17, 2018.
5. Bartlett, J.G., Clinical practice. Antibiotic-associated diarrhea. N. Engl. J. Med. 346 (2002), 334–339.
6. Bolger, A.M., Lohse, M., Usadel, B., Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30 (2014), 2114–2120.
7. Caballero, S., Kim, S., Carter, R.A., Leiner, I.M., Sušac, B., Miller, L., Kim, G.J., Ling, L., Pamer, E.G., Cooperating commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium. Cell Host Microbe 21 (2017), 592–602.
8. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Peña, A.G., Goodrich, J.K., Gordon, J.I., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
9. Cotter, P.D., Ross, R.P., Hill, C., Bacteriocins - a viable alternative to antibiotics?. Nat. Rev. Microbiol. 11 (2013), 95–105.
10. Dethlefsen, L., Relman, D.A., Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. USA 108:Suppl 1 (2011), 4554–4561.
11. Dethlefsen, L., Huse, S., Sogin, M.L., Relman, D.A., The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol., 6, 2008, e280.
12. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., Gingeras, T.R., STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29 (2013), 15–21.
13. Eden, E., Navon, R., Steinfeld, I., Lipson, D., Yakhini, Z., GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics, 10, 2009, 48.
14. Ekmekciu, I., von Klitzing, E., Fiebiger, U., Neumann, C., Bacher, P., Scheffold, A., Bereswill, S., Heimesaat, M.M., The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment. Front. Cell. Infect. Microbiol., 7, 2017, 167.
15. Ferrer, M., Martins dos Santos, V.A., Ott, S.J., Moya, A., Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut Microbes 5 (2014), 64–70.
16. Franker, C.K., Herbert, C.A., Ueda, S., Bacteriocin from Actinomyces odontolyticus with temperature-dependent killing properties. Antimicrob. Agents Chemother. 12 (1977), 410–417.
17. Franz, C.M., van Belkum, M.J., Holzapfel, W.H., Abriouel, H., Gálvez, A., Diversity of enterococcal bacteriocins and their grouping in a new classification scheme. FEMS Microbiol. Rev. 31 (2007), 293–310.
18. Furet, J.-P., Quénée, P., Tailliez, P., Molecular quantification of lactic acid bacteria in fermented milk products using real-time quantitative PCR. Int. J. Food Microbiol. 97 (2004), 197–207.
19. Goossens, D.A., Jonkers, D.M., Russel, M.G., Stobberingh, E.E., Stockbrügger, R.W., The effect of a probiotic drink with Lactobacillus plantarum 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon. Aliment. Pharmacol. Ther. 23 (2006), 255–263.
20. Grazul, H., Kanda, L.L., Gondek, D., Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice. Gut Microbes 7 (2016), 101–114.
21. Haarman, M., Knol, J., Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 71 (2005), 2318–2324.
22. Hempel, S., Newberry, S.J., Maher, A.R., Wang, Z., Miles, J.N., Shanman, R., Johnsen, B., Shekelle, P.G., Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307 (2012), 1959–1969.
23. Herbel, S.R., Lauzat, B., von Nickisch-Rosenegk, M., Kuhn, M., Murugaiyan, J., Wieler, L.H., Guenther, S., Species-specific quantification of probiotic lactobacilli in yoghurt by quantitative real-time PCR. J. Appl. Microbiol. 115 (2013), 1402–1410.
24. Hoskin-Parr, L., Teyhan, A., Blocker, A., Henderson, A.J., Antibiotic exposure in the first two years of life and development of asthma and other allergic diseases by 7.5 yr: a dose-dependent relationship. Pediatr. Allergy Immunol. 24 (2013), 762–771.
25. Huber, J.A., Mark Welch, D.B., Morrison, H.G., Huse, S.M., Neal, P.R., Butterfield, D.A., Sogin, M.L., Microbial population structures in the deep marine biosphere. Science 318 (2007), 97–100.
26. Hyatt, D., Chen, G.L., Locascio, P.F., Land, M.L., Larimer, F.W., Hauser, L.J., Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics, 11, 2010, 119.
27. Jernberg, C., Löfmark, S., Edlund, C., Jansson, J.K., Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 1 (2007), 56–66.
28. Kanehisa, M., Goto, S., KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (2000), 27–30.
29. Klarin, B., Johansson, M.L., Molin, G., Larsson, A., Jeppsson, B., Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit. Care 9 (2005), R285–R293.
30. Kootte, R.S., Levin, E., Salojärvi, J., Smits, L.P., Hartstra, A.V., Udayappan, S.D., Hermes, G., Bouter, K.E., Koopen, A.M., Holst, J.J., et al. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. Cell Metab 26 (2017), 611–619.
31. Köster, J., Rahmann, S., Snakemake–a scalable bioinformatics workflow engine. Bioinformatics 28 (2012), 2520–2522.
32. Kronman, M.P., Zaoutis, T.E., Haynes, K., Feng, R., Coffin, S.E., Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 130 (2012), e794–e803.
33. Langmead, B., Salzberg, S.L., Fast gapped-read alignment with Bowtie 2. Nat. Methods 9 (2012), 357–359.
34. Lankelma, J.M., Cranendonk, D.R., Belzer, C., de Vos, A.F., de Vos, W.M., van der Poll, T., Wiersinga, W.J., Antibiotic-induced gut microbiota disruption during human endotoxemia: a randomised controlled study. Gut 66 (2017), 1623–1630.
35. Lichtman, J.S., Ferreyra, J.A., Ng, K.M., Smits, S.A., Sonnenburg, J.L., Elias, J.E., Host-Microbiota Interactions in the Pathogenesis of Antibiotic-Associated Diseases. Cell Rep. 14 (2016), 1049–1061.
36. Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 2014, 550.
37. Maldonado-Gómez, M.X., Martínez, I., Bottacini, F., O'Callaghan, A., Ventura, M., van Sinderen, D., Hillmann, B., Vangay, P., Knights, D., Hutkins, R.W., Walter, J., Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut Depends on Individualized Features of the Resident Microbiome. Cell Host Microbe 20 (2016), 515–526.
38. Manor, O., Borenstein, E., Revised computational metagenomic processing uncovers hidden and biologically meaningful functional variation in the human microbiome. Microbiome, 5, 2017, 19.
39. Martin, M., Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet 17 (2011), 10–12.
40. McFarland, L.V., Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig. Dis. 16 (1998), 292–307.
41. McFarland, L.V., Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open, 4, 2014, e005047.
42. Olek, A., Woynarowski, M., Ahrén, I.L., Kierkuś, J., Socha, P., Larsson, N., Önning, G., Efficacy and Safety of Lactobacillus plantarum DSM 9843 (LP299V) in the Prevention of Antibiotic-Associated Gastrointestinal Symptoms in Children-Randomized, Double-Blind, Placebo-Controlled Study. J. Pediatr. 186 (2017), 82–86.
43. Peng, Y., Leung, H.C., Yiu, S.-M., Chin, F.Y., IDBA-UD: a de novo assembler for single-cell and metagenomic sequencing data with highly uneven depth. Bioinformatics 28 (2012), 1420–1428.
44. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
45. Risnes, K.R., Belanger, K., Murk, W., Bracken, M.B., Antibiotic exposure by 6 months and asthma and allergy at 6 years: Findings in a cohort of 1,401 US children. Am. J. Epidemiol. 173 (2011), 310–318.
46. Ruggirello, M., Dolci, P., Cocolin, L., Detection and viability of Lactococcus lactis throughout cheese ripening. PLoS ONE, 9, 2014, e114280.
47. Schwendimann, L., Kauf, P., Fieseler, L., Gantenbein-Demarchi, C., Miescher Schwenninger, S., Development of a quantitative PCR assay for rapid detection of Lactobacillus plantarum and Lactobacillus fermentum in cocoa bean fermentation. J. Microbiol. Methods 115 (2015), 94–99.
48. Shao, X., Ding, X., Wang, B., Li, L., An, X., Yao, Q., Song, R., Zhang, J.A., Antibiotic Exposure in Early Life Increases Risk of Childhood Obesity: A Systematic Review and Meta-Analysis. Front. Endocrinol. (Lausanne), 8, 2017, 170.
49. Sharon, I., Morowitz, M.J., Thomas, B.C., Costello, E.K., Relman, D.A., Banfield, J.F., Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization. Genome Res. 23 (2013), 111–120.
50. Smith, M., Kassam, Z., Edelstein, C., Burgess, J., Alm, E., OpenBiome remains open to serve the medical community. Nat. Biotechnol., 32, 2014, 867.
51. Strimmer, K., A unified approach to false discovery rate estimation. BMC Bioinformatics, 9, 2008, 303.
52. Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C.A., Maza, O., Israeli, D., Zmora, N., Gilad, S., Weinberger, A., et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514 (2014), 181–186.
53. Terveer, E.M., van Beurden, Y.H., Goorhuis, A., Seegers, J.F.M.L., Bauer, M.P., van Nood, E., Dijkgraaf, M.G.W., Mulder, C.J.J., Vandenbroucke-Grauls, C.M.J.E., Verspaget, H.W., et al. How to: Establish and run a stool bank. Clin. Microbiol. Infect. 23 (2017), 924–930.
54. Truong, D.T., Franzosa, E.A., Tickle, T.L., Scholz, M., Weingart, G., Pasolli, E., Tett, A., Huttenhower, C., Segata, N., MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods 12 (2015), 902–903.
55. Van Boeckel, T.P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B.T., Levin, S.A., Laxminarayan, R., Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect. Dis. 14 (2014), 742–750.
56. Vangay, P., Ward, T., Gerber, J.S., Knights, D., Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 17 (2015), 553–564.
57. Virta, L., Auvinen, A., Helenius, H., Huovinen, P., Kolho, K.L., Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease–a nationwide, register-based finnish case-control study. Am. J. Epidemiol. 175 (2012), 775–784.
58. Wiström, J., Norrby, S.R., Myhre, E.B., Eriksson, S., Granström, G., Lagergren, L., Englund, G., Nord, C.E., Svenungsson, B., Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J. Antimicrob. Chemother. 47 (2001), 43–50.
59. Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R.N., Anokhin, A.P., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
60. Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell 163 (2015), 1079–1094.
61. Zmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., Kotler, E., Zur, M., Regev-Lehavi, D., Brik, R.B.-Z., et al. Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features. Cell 174 (2018), 1388–1405 this issue.